Marker Therapeutics, Inc. — SC 13G/A Filings
15 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Marker Therapeutics, Inc. (MRKR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Marker Therapeutics, Inc. has filed 15 SC 13G/A documents with the SEC since 1999. To view all SEC filings by Marker Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10KSB40
10QSB
10QSB/A
10SB12G
10SB12G/A
3
3/A
4
4/A
424B3
424B5
424B7
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFM14A
DEFR14A
DEFS14A
DEL AM
EFFECT
NT 10-K
NT 10-Q
NT 10-Q/A
NTN 10K
POS AM
PRE 14A
PRE 14C
PREM14A
PRER14A
PRER14C
PRES14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001193125-20-038347 | Feb 14, 2020 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-19-001621 | Feb 4, 2019 | — |
| SC 13G/A | — | 0000930413-18-000507 | Feb 14, 2018 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-18-000939 | Jan 26, 2018 | — |
| SC 13G/A | — | 0001193805-17-000250 | Feb 14, 2017 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-17-000948 | Feb 6, 2017 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-16-016258 | Aug 19, 2016 | — |
| SC 13G/A | — | 0000930413-16-005298 | Feb 8, 2016 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001144204-16-079372 | Feb 8, 2016 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-16-010454 | Jan 29, 2016 | — |
| SC 13G/A | TAPIMMUNE INC. | 0000902664-16-004887 | Jan 19, 2016 | — |
| SC 13G/A | TAPIMMUNE INC. | 0000902664-15-000091 | Jan 12, 2015 | — |
| SC 13G/A | NONE | 0001140361-14-002820 | Jan 22, 2014 | — |
| SC 13G/A | FORM SC 13G/A | 0001144204-13-052112 | Sep 24, 2013 | — |
| SC 13G/A | SC 13G/A | 0001144204-12-008774 | Feb 14, 2012 | — |